Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer
MS Brown, B Abdollahi, OM Wilkins, H Lu… - Science …, 2022 - science.org
The epithelial-to-mesenchymal transition (EMT) is frequently co-opted by cancer cells to
enhance migratory and invasive cell traits. It is a key contributor to heterogeneity, …
enhance migratory and invasive cell traits. It is a key contributor to heterogeneity, …
[HTML][HTML] NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson's disease
…, MS Feldman, BC Christensen, OM Wilkins… - NPJ Parkinson's …, 2018 - nature.com
Neuroinflammation is a well-characterized pathophysiology occurring in association with
the progression of Parkinson’s disease. Characterizing the cellular and molecular basis of …
the progression of Parkinson’s disease. Characterizing the cellular and molecular basis of …
[PDF][PDF] Inhibition of the proteasome β2 site sensitizes triple-negative breast cancer cells to β5 inhibitors and suppresses Nrf1 activation
ES Weyburne, OM Wilkins, Z Sha, DA Williams… - Cell chemical …, 2017 - cell.com
The proteasome inhibitors carfilzomib (Cfz) and bortezomib (Btz) are used successfully to treat
multiple myeloma, but have not shown clinical efficacy in solid tumors. Here we show that …
multiple myeloma, but have not shown clinical efficacy in solid tumors. Here we show that …
Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells
K Canfield, J Li, OM Wilkins, MM Morrison, M Ung… - Cell Cycle, 2015 - Taylor & Francis
Approximately 25% of breast cancers overexpress and depend on the receptor tyrosine
kinase ERBB2, one of 4 ERBB family members. Targeted therapies directed against ERBB2 …
kinase ERBB2, one of 4 ERBB family members. Targeted therapies directed against ERBB2 …
Kynurenine‐Induced Aryl Hydrocarbon Receptor Signaling in Mice Causes Body Mass Gain, Liver Steatosis, and Hyperglycemia
IY Rojas, BJ Moyer, CS Ringelberg, OM Wilkins… - …, 2021 - Wiley Online Library
Objective The aryl hydrocarbon receptor (AHR) plays a key role in obesity. In vitro studies
revealed that the tryptophan metabolite kynurenine (Kyn) activates AHR signaling in cultured …
revealed that the tryptophan metabolite kynurenine (Kyn) activates AHR signaling in cultured …
[HTML][HTML] Lineage plasticity enables low-ER luminal tumors to evolve and gain basal-like traits
…, NB Ognjenovic, MK Lee, OM Wilkins… - Breast Cancer …, 2023 - Springer
Stratifying breast cancer into specific molecular or histologic subtypes aids in therapeutic
decision-making and predicting outcomes; however, these subtypes may not be as distinct as …
decision-making and predicting outcomes; however, these subtypes may not be as distinct as …
Enrichment of CpG island shore region hypermethylation in epigenetic breast field cancerization
While changes in DNA methylation are known to occur early in breast carcinogenesis and
the landscape of breast tumour DNA methylation is profoundly altered compared with normal …
the landscape of breast tumour DNA methylation is profoundly altered compared with normal …
Dynamic plasticity within the EMT spectrum, rather than static mesenchymal traits, drives tumor heterogeneity and metastatic progression of breast cancers
The Epithelial-to-Mesenchymal Transition (EMT) is a developmental cellular program frequently
coopted by cancer cells 1 and is a key contributor to both heterogeneity in solid tumors 2 …
coopted by cancer cells 1 and is a key contributor to both heterogeneity in solid tumors 2 …
MicroRNA-related genetic variants associated with survival of head and neck squamous cell carcinoma
Background: Head and neck squamous cell carcinoma (HNSCC) is commonly diagnosed at
an advanced stage, and prognosis for such patients is poor. There remains a gap in our …
an advanced stage, and prognosis for such patients is poor. There remains a gap in our …
Genome-scale identification of microRNA-related SNPs associated with risk of head and neck squamous cell carcinoma
Polymorphisms in microRNAs and their target sites can disrupt microRNA-dependent gene
regulation, and have been associated with cancer susceptibility. However, genome-scale …
regulation, and have been associated with cancer susceptibility. However, genome-scale …